7 studies found for:    HR-11-001
Show Display Options
Rank Status Study
1 Completed An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
Condition: Malignant Tumors
Intervention: Drug: Gemcitabine HCl Oral Formulation
2 Completed
Has Results
A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: KW-2478;   Drug: Bortezomib
3 Recruiting Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease
Condition: Graft vs Host Disease
Interventions: Drug: Tacrolimus;   Drug: Cyclosporine;   Drug: Methotrexate
4 Recruiting CORAL XT - Open-label Extension Trial of the CORAL Trial
Conditions: Pain;   Neoplasms;   Chronic Pain
Intervention: Drug: Cebranopadol
5 Terminated
Has Results
A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)
Condition: Neoplasms
Intervention: Drug: MK0683, vorinostat
6 Recruiting Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit
Condition: Cirrhosis With Septic Shock.
Interventions: Drug: Terlipressin;   Drug: Noradrenaline
7 Recruiting Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients
Condition: Kidney; Complications, Allograft
Interventions: Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolic acid

Indicates status has not been verified in more than two years